Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16Ink4a, p19Arf, p53, and p21Waf1/Cip1
Masahiko Obata
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorEmi Imamura
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorYukinori Yoshida
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorJunichi Goto
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorKan Kishibe
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorAtsumi Yasuda
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorCorresponding Author
Katsuhiro Ogawa
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Department of Pathology, Asahikawa Medical College, 2-1-1-1 East, Midorigaoka, Asahikawa 078–8510, Japan.Search for more papers by this authorMasahiko Obata
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorEmi Imamura
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorYukinori Yoshida
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorJunichi Goto
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorKan Kishibe
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorAtsumi Yasuda
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Search for more papers by this authorCorresponding Author
Katsuhiro Ogawa
Department of Pathology, Asahikawa Medical College, Asahikawa, Japan
Department of Pathology, Asahikawa Medical College, 2-1-1-1 East, Midorigaoka, Asahikawa 078–8510, Japan.Search for more papers by this authorAbstract
Primary cultured mouse hepatic cells become senescent within a short period, although rare cells form colonies from which continuously proliferating cell lines can be established. In contrast, hepatic tumor (HT) cells show little senescence and higher colony-forming capacity. To assess this difference, we investigated p16Ink4a/p19Arf/p53/p21Waf1/Cip1 expression in primary normal and HT cells, together with cell lines established from both. In primary normal cells, p16Ink4a/p19Arf were expressed only in association with senescence and disappeared at later stages of colony formation. In contrast, primary HT cells showed sustained p16Ink4a/p19Arf expression from the beginning. No p16Ink4a/p19Arf alterations, such as deletion, mutations, or hypermethylation, were detected in the primary HT cells, although most cell lines derived from either normal or HT cell colonies lost p16Ink4a or p19Arf expression owing to hypermethylation or homozygous deletion of p16Ink4a/p19Arf. On the other hand, primary normal and HT cells and most cell lines showed constitutively elevated expression of p53/p21Waf1/Cip1, with a further increment after ultraviolet ir-radiation, indicating a functionally normal p53 pathway. These results indicate that primary HT cells are resistant to senescence despite retaining p16Ink4a/p19Arf/p53/p21Waf1/Cip1 expression and that loss of p16Ink4a/p19Arf function is associated only with establishment of the cell lines. © 2001 Wiley-Liss, Inc.
REFERENCES
- 1 Hayflick L. Current theories of biological aging. Fed Proc 1975; 34: 9–13.
- 2 Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963; 17: 299–313.
- 3 Ponten J. The relationship between in vitro transformation and tumor formation in vivo. Biochim Biophys Acta 1976; 458: 397–422.
- 4 Newbold RF, Overell RW, Connell JR. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature 1982; 299: 633–635.
- 5 Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991; 93: 59–62.
- 6 Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672–1677.
- 7 Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000; 60: 3689–3695.
- 8 Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999; 9: 22–30.
- 9 Sherr CJ. G1 phase progression: Cycling on cue. Cell 1994; 79: 551–555.
- 10 Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131–134.
- 11 Palmero I, McConnell B, Parry D, et al. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 1997; 15: 495–503.
- 12 Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15: 203–211.
- 13
Prives C,
Hall PA.
The p53 pathway.
J Pathol
1999;
187:
112–126.
10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 14 Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993–1000.
- 15 Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92: 713–723.
- 16 Zhang HS, Gavin M, Dahiya A, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101: 79–89.
- 17 Scott FJ, Bates S, James MC, et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17: 5001–5014.
- 18 Kamijo T, Zindy F, Roussel MF, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91: 649–659.
- 19 El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825.
- 20 Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of cyclin dependent kinases. Cell 1993; 75: 805–816.
- 21 Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–704.
- 22 Gu Y, Turk CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366: 707–710.
- 23 Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90–98.
- 24 Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18: 4974–4982.
- 25 Groth A, Weber JD, Willumsen BM, Sherr CJ, Roussel MF. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D–dependent kinases. J Biol Chem 2000; 275: 27473–27480.
- 26 Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593–602.
- 27 Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 1998; 395: 125–126.
- 28 Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998; 12: 2997–3007.
- 29 Zindy F, Eischen CM, Randle DH, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998; 12: 2424–2433.
- 30 De Stanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev 1998; 12: 2434–2442.
- 31 Bates S, Phillips AC, Clarke P, et al. p14ARF links the tumor suppressors RB and p53. Nature 1998; 395: 124–125.
- 32 Dimri GP, Itahana K, Acosta M, Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol Cell Biol 2000; 20: 273–285.
- 33 Radfar A, Unnikrishnan I, Lee H-W, DePinho RA, Rosenberg N. p19Arf induces p53-dependent apoptosis during Abelson virus–mediated pre-B cell transformation. Proc Natl Acad Sci USA 1998; 95: 13194–13199.
- 34 Smith JR, Pereira-Smith OM. Replicative senescence: Implications for in vivo aging and tumor suppression. Science 1996; 273: 63–67.
- 35 Campisi J. Aging and cancer: The double-edged sword of replicative senescence. J Am Geriatr Soc 1997; 45: 482–488.
- 36
Wynford-Thomas D.
Cellular senescence and cancer.
J Pathol
1999;
187:
100–111.
10.1002/(SICI)1096-9896(199901)187:1<100::AID-PATH236>3.0.CO;2-T CAS PubMed Web of Science® Google Scholar
- 37 Sedivy JM. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc Natl Acad Sci USA 1998; 95: 9078–9081.
- 38 Blasco MA, Lee H-W, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25–34.
- 39 Carman TA, Afshari CA, Barrett JC. Cellular senescence in telomerase-expressing Syrian hamster embryo cells. Exp Cell Res 1998; 244: 33–42.
- 40 Russo I, Silver AR, Cuthbert AP, Griffin DK, Trott DA, Newbold RF. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene 1998; 17: 3417–3426.
- 41 Nishimori H, Ogawa K, Tateno H. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long-term culture of C3H mouse hepatocytes. Int J Cancer 1994; 59: 108–113.
- 42 Yoshie M, Nishimori H, Lee GH, Ogawa K. High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and -resistant mouse strains. Carcinogenesis 1998; 19: 1103–1107.
- 43 Lee GH, Ogawa K, Nishimori H, Drinkwater N. Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the Lci (liver cell immortalization) locus on chromosome 4. Oncogene 1995; 11: 2281–2287.
- 44 Ogawa K, Osanai M, Obata M, Ishizaki K, Kamiya K. Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines. Carcinogenesis 1999; 20: 2083–2088.
- 45
Ishizaki K,
Ogawa K.
Fine mapping of smallest common regions of deletion on chromosome 12 in liver epithelial and hepatocellular carcinoma cell lines from B6C3F1 and C3B6F1 mice.
Int J Cancer
2000;
86:
251–254.
10.1002/(SICI)1097-0215(20000415)86:2<251::AID-IJC15>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 46 Santos J, Perez de Castro I, Herranz M, Pellier A, Fernandez-Piqueras J. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas. Oncogene 1996; 12: 669–676.
- 47 Herzog CR, Wang Y, You M. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 1995; 11: 1811–1815.
- 48 Wiseman RW, Cochran C, Dietrich W, Lander ES, Soderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci USA 1994; 91: 3759–3763.
- 49
Gause PR,
Lluria-Prevatt M,
Keith WN, et al.
Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice.
Mol Carcinog
1997;
20:
78–87.
10.1002/(SICI)1098-2744(199709)20:1<78::AID-MC9>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 50 Quelle DE, Ashmun RA, Hannon GJ, et al. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 1995; 11: 635–645.
- 51 Maronpot RR, Fox T, Malarley DE, Goldsworthy TL. Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 1995; 101: 125–156.
- 52 De La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95: 8847–8851.
- 53 Ogawa K, Yamada Y, Kishibe K, Ishizaki K, Tokusashi Y. β-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Cancer Res 1999; 59: 1830–1833.
- 54 Deveurex TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 1999; 18: 4726–4733.
- 55 Hegi ME, Devereux TR, Dietrich WF, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994; 54: 6257–6264.
- 56 Manenti G, De Gregorio L, Gariboldi M, Dragani TA, Pierotti MA. Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol Carcinog 1995; 13: 191–200.
- 57 Kadohama T, Tsuji K, Ogawa K. Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression. Oncogene 1994; 9: 2845–2852.
- 58 Vesselinovitch SD, Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res 1983; 43: 4253–4259.
- 59 Kreamer BL, Staecker JL, Sawada N, Sattler GL, Hsia MT, Pitot HC. Use of a low-speed, iso-density Percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro Cell Dev Biol 1986; 22: 201–211.
- 60 Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–9826.
- 61 Kamb A, Grius NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–440.
- 62 Nobori T, Miura K, Wu DJ, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756.
- 63 Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995; 1: 686–692.
- 64 Quelle DE, Cheng M, Ashmun RA, Sherr CJ. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci USA 1997; 94: 669–673.
- 65 Asamoto M, Hori T, Baba-Toriyama H, et al. p16 Gene overexpression in mouse bladder carcinomas. Cancer Lett 1998; 127: 9–13.
- 66 Belinsky SA, Swafford DS, Middleton SK, Kennedy CH, Tesfaigzi J. Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis 1997; 18: 115–120.
- 67 Harbour JW, Luo R, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999; 98: 859–869.
- 68 Inoue K, Roussel MF, Sherr CJ. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci USA 1999; 96: 3993–3998.
- 69 Jacobs JJL, Kieboom K, Marino S, Depinho RA, van Lohuizen M. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397: 164–168.
- 70 Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nature Cell Biol 2000; 2: 148–155.
- 71 El-Deiry WS, Tokino T, Waldman T, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55: 2910–2919.
- 72
Qin LF,
Ng IO,
Fan ST,
Ng M.
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
Int J Cancer
1998;
79:
424–428.
10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- 73 Parker SB, Eichele G, Zhang P, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024–1027.
- 74 Burkhart BA, Alcorta DA, Chiao C, Isaacs JS, Barrett JC. Two posttranscriptional pathways that regulate p21Cip1/Waf1/Sdi1 are identified by HPV16-E6 interaction and correlate with life span and cellular senescence. Exp Cell Res 1999; 247: 168–175.
- 75 Gorospe M, Wang X, Holbrook NJ. Functional role of p21 during the cellular response to stress. Gene Express 1999; 7: 377–385.
- 76 Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501–1512.
- 77 Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831–834.
- 78 Dulic V, Beney GE, Frebourg G, Drullinger LF, Stein GH. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol 2000; 20: 6741–6754.